Williams, A.F., Vadgama, A., Franks, P.J. and Mortimer, P.S. (2002) A Randomized Controlled Crossover Study of Manual Lymphatic Drainage Therapy in Women with Breast Cancer-Related Lymphoedema. European Journal of Cancer Care, 11, 254-261.
https://doi.org/10.1046/j.1365-2354.2002.00312.x

has been cited by the following article:

• TITLE: Efficacy of Manual Lymphatic Drainage for Breast Cancer-Related Lymphedema

  AUTHORS: Na Li, Qi Wu, Feng Liu, Liping Zhang, Lijuan Zhang, Qiaoling Zhong, Huizhen Zhang

  KEYWORDS: Manual Lymphatic Drainage, Meta-Analysis, Breast Cancer Lymphedema

  JOURNAL NAME: Advances in Breast Cancer Research, Vol.11 No.2, April 18, 2022

  ABSTRACT: Purpose: The effect of manual lymphatic drainage in patients with breast cancer is controversial. The purpose of this study is to evaluate the role of manual lymphatic drainage (MLD) in breast cancer-related lymphedema treatment. Methods: The electronic databases of EMBASE, PubMed, Web of Science, and The Cochrane Library were searched to find English articles on MLD which were published before January 2020. After two evaluators selected the studies and independently evaluated literature quality, meta-analysis was carried out with RevMan 5.3 software. The outcome index of lymphedema treatment changed in edema volume. Results: The study included six RCTs of 364 patients and the meta-analysis showed no significant difference in the effect of MLD for BCRL compared with other treatments (mean difference, 3.76; 95% confidence interval, -35.09 to 42.62; Z, 0.19; p = 0.850). Conclusion: MLD can relieve the body tissue, rapidly improve local condition, and enhance complete decongestive therapy (CDT) efficacy. MLD can prevent BCRL and improve the symptoms of stage I lymphedema. It should be widely applied to prevent BCRL from entering an irreversible state.